In the studies carried out by Terrisse et al. [129], the ApoD concentration in the CSF of AD patients (4.23 ± 1.58 μg/mL, p < 0.0001) was 3–4 times higher as compared to the control group (1.15 ± 0.71 μg/mL). Here, APOD is linked to Alzheimer disease.